PVLA
Palvella Therapeutics, Inc
132.50$
-0.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +11.3% | – | – | – | – | |
| – | – | – | +41.2% | +37.6% | +671.2% | |
| – | – | -94.7% | -294.3% | – | – | |
| – | -65.2% | +9.7% | -100.0% | – | – | |
| – | -102.4% | +2,137.7% | – | – | – | |
| – | – | – | – | – | -100.0% | |
| – | +484.5% | -83.8% | -47.7% | +1,641.8% | -100.8% | |
| – | +478.9% | -111.1% | – | – | -133.6% | |
| – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.